This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Cyclandelate" – news · newspapers · books · scholar · JSTOR (October 2021) (Learn how and when to remove this message) |
Clinical data | |
---|---|
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
ATC code | |
Identifiers | |
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.006.611 |
Chemical and physical data | |
Formula | C17H24O3 |
Molar mass | 276.376 g·mol |
3D model (JSmol) | |
Melting point | 55 to 56.5 °C (131.0 to 133.7 °F) |
Boiling point | 192 to 194 °C (378 to 381 °F) (14 mmHg) |
SMILES
| |
InChI
| |
(verify) |
Cyclandelate is a vasodilator used in the treatment of claudication, arteriosclerosis and Raynaud's disease. It is also used to treat nighttime leg cramps, and has been investigated for its effect against migraine. It is orally administered.
References
- Smith AL (January 1965). "Cyclandelate (Cyclospasmol) in the Treatment of Peripheral Circulatory Diseases". Angiology. 16: 1–7. doi:10.1177/000331976501600101. PMID 14258038.
Peripheral vasodilators (C04) | |
---|---|
Phenylethanolamine derivatives | |
Alpha blockers |
|
Niacin and derivatives | |
Purine derivatives | |
Ergot alkaloids | |
Other peripheral vasodilators |
This drug article relating to the cardiovascular system is a stub. You can help Misplaced Pages by expanding it. |